Company profile
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
- CEO
- Mr. Marshall Chapin
- Headquarters
- Edinburgh, United Kingdom
- Employees
- —
- IPO date
- Oct 11, 2016
- Sector
- Healthcare
- Industry
- Biotechnology